Your browser doesn't support javascript.
loading
Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay.
Martínez-Pinilla, Eva; Rabal, Obdulia; Reyes-Resina, Irene; Zamarbide, Marta; Navarro, Gemma; Sánchez-Arias, Juan A; de Miguel, Irene; Lanciego, José L; Oyarzabal, Julen; Franco, Rafael.
Afiliación
  • Martínez-Pinilla E; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Rabal O; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Reyes-Resina I; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Zamarbide M; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Navarro G; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Sánchez-Arias JA; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • de Miguel I; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Lanciego JL; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Oyarzabal J; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
  • Franco R; Neurosciences Division (E.M.-P., M.Z., J.L.L.) and Small Molecule Discovery Platform, Molecular Therapeutics Program (O.R., J.A.S.-A., I.d.M., J.O.), Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Instituto de Neurociencias del Principado de Asturias, Departamento de Mo
J Pharmacol Exp Ther ; 358(3): 580-7, 2016 09.
Article en En | MEDLINE | ID: mdl-27358483

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bioensayo / Receptor Cannabinoide CB2 Límite: Humans Idioma: En Revista: J Pharmacol Exp Ther Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bioensayo / Receptor Cannabinoide CB2 Límite: Humans Idioma: En Revista: J Pharmacol Exp Ther Año: 2016 Tipo del documento: Article